Skip to Main Content

Paper Details

Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles.
Clin Pharmacol Ther
5
2022
CYP2C9*5, CYP2C9*5 SNV, CYP2C9*5 Variant Alleles, Patients, SNV, SNVs, Warfarin, WarfarinDosing, allele, cytochrome P450 2C9*5, cytochrome P450 2C9*5 (CYP2C9*5) allele, patients, single-nucleotide variation, warfarin
Author NameAffiliation
Nita A LimdiUniversity of Alabama at Birmingham
Larisa H CavallariUniversity of Florida
Julie A JohnsonUniversity of Florida
Alan H B WuUniversity of California at San Francisco
Paul M RidkerBrigham and Women's Hospital, Harvard Medical School
Timothy M BeasleyUniversity of Alabama at Birmingham
  • 1 - 6

Datasets

Release 1.2